Test Price
3,200 AED✅ Home Collection Available
GATA2 Full-Length Gene Sequencing (Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, AML) in UAE
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Sample Collection: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation with DHA-licensed clinicians.
- Insurance: Direct Billing Verification available via WhatsApp at +971 54 548 8731; all major UAE insurers accepted.
Test Overview & Methodology
GATA2 full‑length gene sequencing detects all coding‑region variants associated with GATA2 deficiency, a complex haploinsufficiency syndrome that manifests as chronic neutropenia, MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. This comprehensive Sanger‑based analysis delivers the highest clinical specificity for hereditary myeloid disorders, enabling targeted surveillance and early intervention.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Sequencing Method | Sanger Sequencing (Gold Standard) | Targeted Next‑Generation Sequencing (NGS) Panel |
| GATA2 Coverage | Entire coding region & splice sites | Often restricted to hotspot exons |
| Turnaround Time | 15 working days | 10–25 days |
| Price | 3200 AED (all‑inclusive) | 2800–3800 AED (varies by lab) |
| Diagnostic Sensitivity | ≥99.9% for SNVs/indels | 95–98%, depends on capture design |
| DHA Compliance | Full DHA/MOHAP protocol | May lack UAE regulatory certification |
| Insurance Direct Billing | Yes (via WhatsApp verification) | Often out‑of‑pocket only |
Physician Insight & Safety Protocols
“GATA2 mutations can alter hematopoiesis and immune function across a lifetime. This full-length sequencing pinpoints the exact variant, allowing us to map a tailored surveillance plan. Clinical correlation with personal and family history remains essential for safe decision-making.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Do Not Discontinue Medication
Genetic test results are for diagnostic and surveillance purposes only. Do not stop any prescribed medication or alter treatment without consulting your physician. This test does not replace ongoing clinical management.
Exclusion Criteria & ER Red Flags
- This test is not for emergency diagnosis of acute leukemia or acute infection; it is an elective prognostic/surveillance tool.
- Hospital collection should be postponed if you have a fever ≥38.5°C, active bleeding, or a platelet count below 20 × 10⁹/L.
- A valid DHA‑compliant physician order is mandatory. Additional clinical clearance is required prior to scheduling for patients undergoing surgery, pregnancy, or planning international travel.
- If you experience sudden shortness of breath, uncontrolled bleeding, or severe bone pain, proceed to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What does GATA2 full-length gene sequencing detect?
GATA2 full-length gene sequencing identifies all coding‑region mutations linked to MonoMac syndrome, chronic neutropenia, myelodysplasia, and acute myeloid leukemia with near‑perfect sensitivity (≥99.9%).
2. Who should consider having this genetic test?
Individuals with unexplained chronic neutropenia, recurrent atypical mycobacterial infections, familial MDS/AML history, or clinical suspicion of MonoMac syndrome are candidates for this test.
3. How is the sample collected and when will I receive results?
The sample is collected via venous blood draw or bone marrow aspirate by a DHA-licensed professional within an accredited hospital. Results are delivered in 15 working days with telephonic clinical guidance from a DHA-licensed clinician.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genomic and personal health data are encrypted and disclosed only to the ordering physician and the patient via secure channels.
Accreditation: Sample processing is performed in an ISO 9001:2015‑certified facility (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | GATA2 Full-Length Gene Sequencing (Chronic Neutropenia, MonoMac Syndrome, Myelodysplasia, AML) |
| Price (AED) | 3,200 |
| Turnaround Time | 15 working days |
| Sample Type / Matrix | Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Sanger Sequencing (Gold Standard) |
| ICD-10-CM Code | D61.81 (Pancytopenia), D46.9 (Myelodysplastic syndrome), C92.0 (Acute myeloid leukemia) |
| LOINC Code | 68880-7 (GATA2 gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | DNA Labs UAE, DHA Facility License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians